Cargando…
Interpretation and Use of Natriuretic Peptides in Non-Congestive Heart Failure Settings
Natriuretic peptides (NPs) have been found to be useful markers in differentiating acute dyspneic patients presenting to the emergency department (ED) and emerged as potent prognostic markers for patients with congestive heart failure (CHF). The best-established and widely used clinical application...
Autores principales: | Tsai, Shih-Hung, Lin, Yen-Yue, Chu, Shi-Jye, Hsu, Ching-Wang, Cheng, Shu-Meng |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824858/ https://www.ncbi.nlm.nih.gov/pubmed/20191004 http://dx.doi.org/10.3349/ymj.2010.51.2.151 |
Ejemplares similares
-
Inverse association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patients
por: Wang, Ji-Hung, et al.
Publicado: (2013) -
Cardiac congestion assessed by natriuretic peptides oversimplifies the definition and treatment of heart failure
por: Palazzuoli, Alberto, et al.
Publicado: (2021) -
Correlation of natriuretic peptides and inferior vena cava size in patients with congestive heart failure
por: Hebl, Virginia, et al.
Publicado: (2012) -
Great Tool or Gold Standard? B-Type Natriuretic Peptide and Congestive Heart Failure
por: Montez, Jeremy, et al.
Publicado: (2011) -
Inverse Association of N-Terminal Pro-B-Type Natriuretic Peptide with Metabolic Syndrome in Patients with Congestive Heart Failure
por: Chang, Huai-Ren, et al.
Publicado: (2013)